Clinical Guidelines and Real Practice of Antimicrobial Pharmacotherapy
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 463
Special Issue Editor
Interests: adverse drug reaction; drug-drug interaction; patient adherence; antimicrobial resistance; clinical guidelines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Clinical guidelines for antimicrobial pharmacotherapy are crucial tools that are based on extensive research, expert consensus, and clinical trials for optimising the treatment of infections. They outline the best practices for selecting effective drugs, appropriate dosing, and treatment duration in order to standardise treatment, minimise antimicrobial resistance, and optimise drug efficacy and safety. However, the gap between these guidelines and real-world practice can be significant.
In clinical settings, variability in patient populations, comorbidities, and unique clinical scenarios necessitate deviations from standardised protocols. Clinicians may also face limitations such as drug availability, patient allergies, the pressure to prescribe quickly to address patient concerns, or limited access to diagnostic testing. Additionally, the dynamic nature of microbial resistance patterns requires the continuous adaptation of prescribed therapies, which is sometimes beyond the scope of existing guidelines.
Therefore, while clinical guidelines are a critical foundation for antimicrobial therapy, real-world practice demands a flexible, individualised approach. Clinicians must balance adherence to guidelines with the nuanced needs of their patients, thereby ensuring effective treatment and mitigating the development of resistance.
Indeed, tailoring guidelines to consider regional factors and implementing antimicrobial stewardship programs that promote responsible prescribing can optimise antibiotic use in real-world settings.
Accordingly, I invite you to contribute to this Special Issue of Antibiotics, titled “Clinical Guidelines and Real Practice of Antimicrobial Pharmacotherapy”.
Dr. Darko Modun
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adverse drug reaction
- patient adherence
- antimicrobial resistance
- clinical guidelines
- clinical settings
- regional factors
- pharmacotherapy
